GLIS3 and Insulin resistance: We further demonstrated that the GLIS3 rs7034200C/A variant contributes to insulin resistance, glucolipid metabolic disorders, and oxidative stress imbalance in the study population, thus may be involved in the pathophysiology of GDM.